Paul R. Fonteyne Covetrus, Inc. (CVET) insider trading activity

CVET Quotes by TradingView

Paul R. Fonteyne is Director of COVETRUS, INC.. Currently has a direct ownership of 0 shares of CVET, which is worth approximately $0. The most recent transaction as insider was on Oct 13, 2022, when has been sold 13,275 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

PAUL R. FONTEYNE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 13 2022
SELL
Sale (or disposition) back to the issuer
-
13,275 Reduced 100.0%
0 Common Stock
Jul 01 2022
BUY
Exercise of conversion of derivative security
-
8,275 Added 38.4%
13,275 Common Stock
Aug 10 2021
BUY
Open market or private purchase
$116,200 $23.24 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
Director
APLS
Apellis Pharmaceuticals, Inc. Healthcare
Director
AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
GLS
GELESIS HOLDINGS, INC. Healthcare
Director
PRF

Paul R. Fonteyne

Director
Portland, ME

Track Institutional and Insider Activities on CVET

Follow COVETRUS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVET shares.

Notify only if

Insider Trading

Get notified when an Covetrus, Inc. insider buys or sells CVET shares.

Notify only if

News

Receive news related to COVETRUS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CVET